Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5683620 | Revista Médica Clínica Las Condes | 2017 | 10 Pages |
Abstract
Acute Coronary Syndrome (ACS), with or without ST-Segment elevation, is most common clinical expressions of Coronary Heart Disease, and one of the main causes of mortality in our country. The Elderly with increasing life expectancy, represent an increasingly important segment of the population, which usually has a higher risk of suffering from an ACS. Better control of cardiovascular risk factors, as well as progress in the diagnosis and treatment of coronary heart disease, has led to an increase in the number of elderly persons at risk for ACS, and are not properly represented in clinical trials. The basics of therapy are set in numerous controlled clinical studies, with more younger patients with less comorbidity, so their conclusions do not necessarily apply to the elderly. On the other hand, almost half of ACS occur in elderly patients, which has a worse clinical course and an evident higher mortality. The diagnosis is more complex due to the lower frequency of pain, more frequent baseline electrocardiographic alterations, and the presence of comorbidity and frailty Current. ACS therapy is based on dual platelet anti-aggregation and anticoagulation with the obvious risk of bleeding in the elderlyt. A strategy for the diagnosis and early management of ACS should be defined in the elderly, which should be individualized for the general condition of the patient
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Dr. Llancaqueo,